Amphastar Pharmaceuticals Inc
NASDAQ:AMPH

Watchlist Manager
Amphastar Pharmaceuticals Inc Logo
Amphastar Pharmaceuticals Inc
NASDAQ:AMPH
Watchlist
Price: 45.06 USD -0.92% Market Closed
Market Cap: 2.2B USD
Have any thoughts about
Amphastar Pharmaceuticals Inc?
Write Note

Amphastar Pharmaceuticals Inc
Total Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Amphastar Pharmaceuticals Inc
Total Equity Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive Total Equity Analysis
Latest Figures & CAGR of Competitors

Company Total Equity CAGR 3Y CAGR 5Y CAGR 10Y
Amphastar Pharmaceuticals Inc
NASDAQ:AMPH
Total Equity
$713.3m
CAGR 3-Years
19%
CAGR 5-Years
13%
CAGR 10-Years
10%
Johnson & Johnson
NYSE:JNJ
Total Equity
$70.2B
CAGR 3-Years
0%
CAGR 5-Years
4%
CAGR 10-Years
-1%
Bristol-Myers Squibb Co
NYSE:BMY
Total Equity
$17.1B
CAGR 3-Years
-23%
CAGR 5-Years
-1%
CAGR 10-Years
1%
Pfizer Inc
NYSE:PFE
Total Equity
$87.7B
CAGR 3-Years
5%
CAGR 5-Years
6%
CAGR 10-Years
1%
Merck & Co Inc
NYSE:MRK
Total Equity
$44.5B
CAGR 3-Years
8%
CAGR 5-Years
11%
CAGR 10-Years
0%
Eli Lilly and Co
NYSE:LLY
Total Equity
$14.2B
CAGR 3-Years
22%
CAGR 5-Years
33%
CAGR 10-Years
-2%

See Also

What is Amphastar Pharmaceuticals Inc's Total Equity?
Total Equity
713.3m USD

Based on the financial report for Jun 30, 2024, Amphastar Pharmaceuticals Inc's Total Equity amounts to 713.3m USD.

What is Amphastar Pharmaceuticals Inc's Total Equity growth rate?
Total Equity CAGR 10Y
10%

Over the last year, the Total Equity growth was 21%. The average annual Total Equity growth rates for Amphastar Pharmaceuticals Inc have been 19% over the past three years , 13% over the past five years , and 10% over the past ten years .

Back to Top